The Courage to Be First: China’s CAR-T Pioneer, “Emily of China,” Celebrates 6 Years in Complete Remission!

### The Courage to Be First: China’s CAR-T Pioneer, “Emily of China,” Celebrates 6 Years in Complete Remission!

Patient Story

#CART #PatientStory #lymphoma #TP53 #DLBCL #CARTTherapy

Meet Mrs. Qin, a true fighter and the first brave patient in China to receive Fosun Kite’s Axicabtagene Ciloleucel in a CAR-T clinical trial. Her story is one of hope, perseverance, and the power of innovation.

In early 2017, a routine check-up uncovered a small lump in her neck, leading to a diagnosis of diffuse large B-cell lymphoma (DLBCL) with a TP53 gene mutation—a high-risk condition. After enduring 12 rounds of grueling chemotherapy, the cancer still returned. Just when hope seemed to be fading, Mrs. Qin became the first patient in China to join a groundbreaking CAR-T therapy trial at Ruijin Hospital under the care of Dr. Zhao Weili. She was a pioneer, much like Emily Whitehead in the U.S., the world’s first pediatric patient to receive CAR-T therapy.

Mrs. Qin recalls the challenging days of her treatment, which involved high fevers and fatigue, yet the unwavering support of Dr. Zhao’s team helped her push through. The cutting-edge CAR-T treatment not only controlled the tumor but led her into complete remission. Six years later, she remains cancer-free and now serves as a volunteer at the hospital, inspiring others who are fighting the same battle.

During the first “CAR-T Therapy Survivor Conference” in Wuhan of China, Mrs. Qin took the stage to share her emotional journey. Her story moved everyone in attendance, from fellow patients to medical experts, as she expressed gratitude for the love and care she received. “Ruijin Hospital is not just where I found a new lease on life, but a home filled with compassion and world-class medical expertise,” she shared.

Mrs. Qin’s tale of courage is a beacon of hope for those still battling the disease. Her message is simple: “No matter how tough the road, never lose faith. After every storm, the rainbow will appear.”

🎉🎉To assess whether the condition is suitable for clinic therapy, you can submit Advanced Medicine in China for preliminary evaluation!

WhatsApp: +8613717959070

Https://wa.me/+8613717959070

Email: doctor.huang@globecancer.com

#ChinaCAR-T #CAR-TTherapy #CancerSurvivor #MedicalBreakthrough #FosunKite #DLBCL #CancerRemission #InnovativeMedicine #HopeHealing #RuijinHospital #ChineseMedicalPioneers #PatientStories #EmilyofChina